Skip to main content

Enzymatics Licenses Enzyme Technology from Massey University Researcher

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzymatics has licensed technology from a New Zealand research facility that could allow genomic sequencing to be done more cheaply and quickly, Massey University said this week.

The enzyme technology was developed in the laboratory of Wayne Patrick, a senior lecturer in biochemistry at the Institute of Natural Sciences at the university, and involves a new method of engineering ligase by fusing DNA-binding proteins to the ligase enzyme.

The result is a family of "more active and efficient" DNA ligases, the university said in a statement.

Enzymatics, a molecular biology enzyme manufacturing firm, will further develop, manufacture, and market the improved enzymes, Massey University said.

Terms of the deal were not disclosed. Enzymatics, based in Beverly, Mass., did not respond to a request for comment.

Patrick said his research tackles fundamental questions about the evolution of enzyme structure and function. "We used that fundamental understanding to help us engineer biomolecules with new or improved functions," he said.

The technology covered by Enzymatics' licensing agreement is especially applicable to next-generation sequencing and could lead to the faster development of personalized medicine, the university said.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.